Literature DB >> 3892222

Tularemia: a 30-year experience with 88 cases.

M E Evans, D W Gregory, W Schaffner, Z A McGee.   

Abstract

Drawing upon our experience with 88 cases and a survey of the English literature, we reviewed the clinical, pathophysiological, and epidemiological aspects of tularemia. Tularemia can be thought of as two syndromes--ulceroglandular and typhoidal. This dichotomy simplifies earlier nomenclature and emphasizes the obscure typhoidal presentation. Clinical manifestations suggest that the two syndromes reflect differences in host response. In ulceroglandular tularemia the pathogen appears to be well contained by a vigorous inflammatory reaction. Pneumonia is less common and the patient's prognosis is good. In typhoidal disease there are few localizing signs; pneumonia is more common; and the mortality without therapy is much higher, suggesting that the host response is somehow deficient. Francisella tularensis is an extremely virulent pathogen capable of initiating infection with as few as 10 organisms inoculated subcutaneously. During an incubation period of 3 to 6 days the host responds first with polymorphonuclear leukocytes and then macrophages. Granulocytes are unable to kill the pathogen without opsonizing antibody leaving cellular immunity to play the major role in host defense. One to 2 weeks after infection, a vigorous T-lymphocyte response can be detected in vitro with lymphocyte blast transformation assays and in vivo with an intradermal skin test, which, unfortunately, is not commercially available. Humoral immunity, often used as a diagnostic modality, appears 2 to 3 weeks into the illness. Cellular immunity is long-lasting, accounting for the common reoccurrence of localized disease upon repeated exposures to the pathogen. There are no symptoms that distinguish the ulceroglandular from the typhoidal syndrome. A pulse-temperature dissociation is seen in less than half of the patients. The location of ulcers and enlarged lymph nodes give a clue to the likely vector since lesions located on the upper extremities are more commonly associated with mammalian, and those of the head and neck and lower extremities with arthropod, vectors. Pharyngitis, pericarditis, and pneumonia can complicate both syndromes, although the latter is much more common in typhoidal disease. Hepatitis, usually of a mild degree, is common and occasionally erythema nodosum is seen. No specific laboratory tests characterize tularemia, and cultures of the pathogen are often difficult to obtain because of the special growth requirements of Francisella tularesis and the inability of many clinical laboratories to handle the dangerous pathogen.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3892222

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  76 in total

Review 1.  Use of aminoglycosides in treatment of infections due to intracellular bacteria.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

Review 2.  Recognizing the real threat of biological terror.

Authors:  Richard P Wenzel
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

3.  Treatment of tularemia with ciprofloxacin.

Authors:  O Scheel; R Reiersen; T Hoel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

4.  Francisella tularensis Exposure Among National Park Service Employees During an Epizootic: Devils Tower National Monument, Wyoming, 2015.

Authors:  Alexia Harrist; Cara Cherry; Natalie Kwit; Katie Bryan; Ryan Pappert; Jeannine Petersen; Danielle Buttke; David Wong; Christina Nelson
Journal:  Vector Borne Zoonotic Dis       Date:  2018-12-01       Impact factor: 2.133

5.  Intranasal interleukin-12 treatment promotes antimicrobial clearance and survival in pulmonary Francisella tularensis subsp. novicida infection.

Authors:  Michael A Pammit; Varija N Budhavarapu; Erin K Raulie; Karl E Klose; Judy M Teale; Bernard P Arulanandam
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

6.  Tularemia after a dormouse bite in Switzerland.

Authors:  A Friedl; I Heinzer; H Fankhauser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-05       Impact factor: 3.267

7.  Tularemia presenting as an isolated pleural effusion.

Authors:  L M Funk; S Q Simpson; G Mertz; J Boyd
Journal:  West J Med       Date:  1992-04

8.  Isolation of Francisella tularensis from blood.

Authors:  J M Provenza; S A Klotz; R L Penn
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

9.  Tularemia in children.

Authors:  Solmaz Celebi; Mustafa Hacimustafaoglu; Suna Gedikoglu
Journal:  Indian J Pediatr       Date:  2008-09-22       Impact factor: 1.967

10.  Characterization of two unusual clinically significant Francisella strains.

Authors:  J E Clarridge; T J Raich; A Sjösted; G Sandström; R O Darouiche; R M Shawar; P R Georghiou; C Osting; L Vo
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.